MSCI reshuffle 2026: Laurus Labs, Lenskart, Adani Energy Solutions and Groww enter the MSCI India Index. Check $1.5 billion inflows,…
Nifty’s short-covering rally may extend as Metal and Healthcare flash bullish setups; watch Torrent Pharma, Apollo and key levels Monday.
Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!
Despite a sluggish broader market, these four midcap stocks delivered 100%+ returns. Here’s why.
Check upcoming dividend payouts from leading Indian companies this May—review record dates and secure your returns!
Over 200 companies, including Vedanta and HUL, will announce key Q4FY26 results this week. Stay updated on dividends and market…
Pharma stocks fall as Nifty Pharma drops 3%. Sun Pharma, Cipla slide amid US tariff fears and export risk concerns.
Jefferies has refreshed its India stock ideas, adding SBI, JSW Steel, Groww and five other companies to its ‘Buy’ list…
Let’s take a look at 5 best CDMO pharma stocks in India.
Motilal Oswal turns bullish on Bharti Airtel, Hyundai Motor India, Laurus Labs and Cummins India, flagging up to 25% upside…
Key stocks including Adani Green, Bandhan Bank, and IndiGo report earnings today—check updates and see which shares are moving.
From commodity exchanges to pharma and auto parts, seven Indian stocks quietly doubled from 52-week lows. Is your portfolio on…
APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government…
JPMorgan says India’s CRDMO market will grow to $15.4 billion by 2029, driven by China+1, regulatory edge and cost advantage,…
Mukul Agrawal bought 2 stocks in 2025, and they have already created ripples in the investor circles with returns of…
India’s API market, valued at US$14.2 billion in 2025, is racing ahead at 8.5% CAGR, and 3 pharma stocks are…
Since early October 2025, the Indian stock market has recovered well. The Nifty50 is currently trading close to its 52-week…
Stay updated on stocks to watch as key defence, pharma, and manufacturing firms announce major deals and approvals—read the latest…